Related Experiment Videos
Statin-related adverse events: a meta-analysis
Matthew A Silva1, Anna C Swanson, Pritesh J Gandhi
1Massachusetts College of Pharmacy and Health Sciences, Worcester, Massachusetts 01608, USA. msilva@wor.mcphs.edu
Clinical Therapeutics
|February 24, 2006
Summary
Statins increase adverse events (AEs) slightly but offer significant cardiovascular benefits. Serious AEs are rare, and the benefits of statin therapy outweigh the risks for most patients.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Clinical Trials
Background:
- Adverse events (AEs) from statin therapy are infrequent in clinical trials, complicating interpretation.
- Understanding the risk-benefit profile of statins is crucial for clinical decision-making.
Purpose of the Study:
- To synthesize adverse event data from prospective randomized clinical trials of statin monotherapy.
- To provide a clearer clinical interpretation of statin-associated risks and benefits.
Main Methods:
- Systematic review of MEDLINE/EMBASE and Cochrane databases for randomized trials of statin monotherapy.
- Inclusion of primary and secondary prevention trials; exclusion of non-randomized or incomplete data studies.
- Meta-analysis using Mantel-Haenszel methods to calculate odds ratios (ORs) for adverse events and cardiovascular outcomes.
Main Results:
- Analysis of 18 trials with 71,108 participants revealed statins increased any AE risk by 39% (OR=1.4).
- Statins reduced cardiovascular event risk by 26% (OR=0.74), with 37 events prevented per 1000 patients treated.
- Serious AEs like rhabdomyolysis were rare (NNH=7428); atorvastatin showed the highest AE risk, fluvastatin the lowest.
- Non-urgent AEs (myalgia, liver elevations) comprised two-thirds of reported events.
Conclusions:
- Statin therapy is associated with a modest increase in overall adverse events but provides significant clinical cardiovascular benefits.
- The rates of serious adverse events were similar between statin and placebo groups, indicating a favorable safety profile for serious complications.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:21Skeletal Muscle Relaxants: Adverse Effects
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...